SEOUL, South Korea (AP) — South Korean President Yoon Suk Yeol has dusted off his golf clubs in an attempt to forge a bond with President-elect Donald Trump, an avid lover of the game.
The presidential office said Tuesday that Yoon began practicing the game for the first time in eight years in preparation for a possible round of golf with Trump.
Since his election, Trump’s “America first” approach has raised concerns it could negatively affect the U.S. defense commitment to South Korea and hurt the trade interests of the Northeast Asian country in various ways, including increased tariffs.
Some experts say it’s important to build a close personal friendship with Trump during the transition period before he formally takes office in January.
“Much could depend on whether Yoon is able to strike up positive chemistry with Trump immediately during the transition and foster a close personal friendship to convince him to want to support and advance Seoul’s interests,” said Duyeon Kim, a senior analyst at the Center for a New American Security in Washington.
Yoon and Trump discussed strengthening bilateral cooperation and agreed to hold an in-person meeting soon during a phone call on Thursday. The South Korean president told reporters later that while things couldn't remain the same as under the Biden administration, "we have been preparing to hedge these risks for a long time.”
And apparently, a game of golf may be what's needed.
Local media said Yoon went to a Seoul golf course on Saturday, but the presidential office said it couldn't confirm the reports.
A senior presidential official, speaking on condition of anonymity in a background briefing, said that while he didn’t know how hard Yoon practiced golf, training was necessary as “our president also has to hit a ball properly to get conversations going on” with Trump, who has “outstanding” golf skills.
Yoon isn’t the first world leader to try to use golf to develop relations with Trump.
When he was in office, Japan’s assassinated prime minister, Shinzo Abe, struck up a personal friendship with then-President Trump, on the greens of golf clubs both in Japan and the U.S. In 2017, Abe said that a round of golf with Trump was a good chance to relax and discuss difficult issues.
FILE - Former President Donald Trump plays during the pro-am round of the Bedminster Invitational LIV Golf tournament in Bedminster, NJ., on July 28, 2022. (AP Photo/Seth Wenig, File)
FILE - South Korean President Yoon Suk Yeol answers a reporters' question during a news conference at the Presidential Office in Seoul, South Korea, Thursday, Nov. 7, 2024. (Kim Hong-Ji/Pool Photo via AP, File)
LILLE, France & PARIS--(BUSINESS WIRE)--Nov 28, 2024--
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241127719655/en/
Dev4All, 4P-Pharma's cutting-edge R&D booster, announces a strategic collaboration with Pharmaseed, an established Contract Research Organization (CRO) with over 20 years of expertise in preclinical drug development.
This partnership combines the strengths of both organizations to offer an integrated, end-to-end approach for preclinical development. Together, Dev4All and Pharmaseed aim to deliver comprehensive and competitive solutions that accelerate drug development and address the complexities of today’s R&D landscape.
With over two decades of experience in CRO services and ten years advancing drug development candidates from TRL3 to TRL5, this close cooperation provides tailored preclinical support, cutting-edge laboratory capabilities, and strategic expertise, complementing clients’ R&D efforts worldwide.
Revital Rattenbach, Executive Chair of Dev4All, said: "I am thrilled about the new collaboration between Dev4All and Pharmaseed, which marks an exciting step forward in our shared commitment to innovation. This commercial cooperation empowers us to scale our capabilities, elevate our global impact, and deliver tailor-made solutions that meet our client's needs while maintaining the highest standards of scientific rigor."
Shmuel Landau, Co-CEO of Pharmaseed, said: "This collaboration with Dev4All is an excellent opportunity to expand our European presence and integrate our comprehensive preclinical solutions with DEV4ALL innovative R&D platform. Together, we are committed to deliver top-tier services, ensuring clients achieve their scientific and clinical milestones."
About Dev4All:
Dev4All, powered by 4P-Pharma, is an R&D booster designed to provide a wide range of preclinical solutions. With a decade-long foundation in preclinical research, Dev4All is committed to transforming innovative ideas into clinical-stage candidates through collaboration and scientific excellence.
Dev4All and Pharmaseed Join Forces in Commercial Cooperation (Graphic: Business Wire)